 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 1391 - 1400 of 2187:
FDA Will Look Into Safety Of BPA In Plastic Yet Again
The U.S. Food and Drug Administration (FDA) will once again look into the safety of bisphenol A, or BPA, in plastic. Last week, a study was released ...
FDA will look into scientist's possible conflict
Federal health officials said Tuesday they will look into a possible conflict of interest involving a prominent toxicologist who is heading up a revie...
FDA Will Wait for Trial Results on Vytorin
The controversy surrounding the highly promoted cholesterol-lowering drug Vytorin continued Friday when U.S. health officials said they would review t...
FDA won't approve Salix drug without another trial
Federal regulators are asking Salix Pharmaceuticals to perform another human trial of an experimental drug before the medicine can be sold in the U.S....
FDA Won’t Implement New Sunscreen Rules for Another Year
It will be at least another year before new standards for sunscreen are enacted by the Food & Drug Administration (FDA). Although some manufacturers ...
FDA would let drugmakers tip doctors to other uses
U.S. health regulators on Friday issued proposed guidelines that would make it easier for pharmaceutical companies to advise doctors about unapproved ...
FDA ‘Mistake’ Tossing Lilly Critic May Slow Prasugrel
Eli Lilly & Co.’s experimental blood thinner prasugrel may face delays getting U.S. approval after regulators said they made a “mistake” removing a c...
FDA's about-face threatens consumer protections
In a case coming before the Supreme Court this fall, the justices will decide whether the Food and Drug Administration's approval of a drug preempts p...
FDA's Approval means $23M for XenoPort
$23 million will be paid to XenoPort Inc.in milestone payments because the Food and Drug Administration accepted a drug application from GlaxoSmithKli...
FDA's approval of Sabril leads to rise in the shares of Lundbeck
Shares in Danish pharmaceuticals group Lundbeck opened higher after the company won U.S. approval on Friday to market a drug to treat severe spasms in... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |